Wave Life Sciences Ltd.

WVE· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$3.52-1.95%

2026-11-02

Financials

Valuation Metrics

Wave Life Sciences Ltd.'s Market Cap is $677M. At end of 2025 it was $3.06B. Ranked #2604 of 3,118 in US market (top 84%), #1104 of 1,474 on NASDAQ (top 75%), #199 of 265 in Pharmaceuticals, Biotechnology & Life Sciences (top 75%) by Market Cap.

Investment Metrics(as of 2026-11-02)

Metric	Value	Rank
Size
Market Cap	$677M	US#2,604/3,118 Sec#199/265
Revenue	$71M	US#2,718/3,118 Sec#137/265
Net Income	$-211M	US—/3,118 Sec—/265
Total Assets	$508M	US#2,752/3,118 Sec#163/265
Net Assets	$402M	US#2,358/3,118 Sec#134/265
Value
P/B	1.69x	US#1,070/3,118 Sec#45/265
P/S	9.55x	US#2,694/3,118 Sec#117/265
FCF Yield	-29.75%	US—/3,118 Sec—/265
Profitability
ROE	-52.38%	US#2,682/3,118 Sec#160/265
ROA	-41.45%	US#2,944/3,118 Sec#192/265
Op. Margin	-320.94%	US#2,761/3,118 Sec#144/265
Revenue Growth	-35.07%	US#2,674/3,118 Sec#154/265
Financial Health
Debt Ratio	26.37%	US#295/3,118 Sec#96/265
Total Debt	$43M	US#2,620/3,118 Sec#158/265
FCF	$-201M	US#2,776/3,118 Sec#209/265
Cash	$197M	US#1,741/3,118 Sec#110/265
Current Ratio	8.38x	US#301/3,118 Sec#90/265
Performance
1Y Return	-61.06%	US#2,941/3,118 Sec#241/265
1M Return	-6.88%	US#2,041/3,118 Sec#136/265
From 52W High	-83.80%	US#3,072/3,118 Sec#254/265
1Y MDD	-85.50%	US#3,081/3,118 Sec#254/265
Trading
Volume	1,871,515 shares	US#616/3,118 Sec#47/265
Trading Value	$7M	US#2,201/3,118 Sec#170/265
Per Share
EPS	$-1.09	US—/3,118 Sec—/265
BPS	$2.09	US#2,563/3,118 Sec#178/265